does glp-1 help with insulin resistance The Role of Receptor Agonists in Concomitant Obesity Treatment in Polycystic Ovary Syndrome Adipose Tissue: A Novel Target

When used with insulin or sulfonylureas, these medications may increase hypoglycemia risk, requiring dose adjustments of those agents

Several randomised control trials have shown a higher rate of gallbladder and biliary disorders in patients using these agents compared with placebo

Read the Terms of Service and Privacy Policy: Before submitting any health information, understand how it's collected, stored, used, and shared

This threshold is sufficiently liberal to ensure the consecutive pathway analysis is conducted on a rich set of exploratory biochemical species

Lancet 359 , 824830 (2002)

Presented at the American Diabetes Association Scientific Sessions